Allarity Therapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.25 | — | — | Miss |
| Q22026 FY2026 | $-0.25 | $-0.21 | +16.0% | Beat |
| Q12026 FY2026 | $-0.22 | $-0.17 | +22.7% | Beat |
| Q42025 FY2025 | $-0.22 | $-0.21 | +4.5% | Beat |
Back to ALLR overview · ALLR holders · ALLR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.